Loading...
XTAEBRIN
Market cap181mUSD
, Last price  
ILS
Name

Brainsway Ltd

Chart & Performance

D1W1MN
XTAE:BRIN chart
P/E
—
P/S
—
EPS
—
Div Yield, %
%
Shrs. gr., 5y
14.78%
Rev. gr., 5y
14.15%
Revenues
32m
+16.96%
364,2491,189,0003,380,0006,800,00011,524,00011,145,00016,397,00023,101,00022,057,00029,657,00027,177,00031,785,000
Net income
-4m
L-68.56%
-5,916,383-7,122,000-6,545,000-4,087,000-2,397,000-7,054,000-6,479,000-10,328,000-5,385,000-6,462,000-13,349,000-4,197,000
CFO
1m
P
-5,603,556-2,363,000-3,793,000-4,552,000-2,402,000-3,467,000-3,773,000-7,244,000-1,436,000884,000-9,759,0001,284,000
Earnings
Mar 04, 2025

Profile

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company primarily serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
URL
https://www.brainsway.com/
IPO date
Dec 24, 2006
Employees
134
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
31,785
16.96%
27,177
-8.36%
Cost of revenue
36,604
39,860
Unusual Expense (Income)
NOPBT
(4,819)
(12,683)
NOPBT Margin
Operating Taxes
251
315
Tax Rate
NOPAT
(5,070)
(12,998)
Net income
(4,197)
-68.56%
(13,349)
106.58%
Dividends
Dividend yield
Proceeds from repurchase of equity
(52)
BB yield
0.09%
Debt
Debt current
232
234
Long-term debt
710
742
Deferred revenue
5,314
4,669
Other long-term liabilities
6,077
6,016
Net debt
(45,043)
(46,876)
Cash flow
Cash from operating activities
1,284
(9,759)
CAPEX
(2,387)
1,936
Cash from investing activities
(37,409)
42,169
Cash from financing activities
(1,026)
(1,547)
FCF
(3,639)
(11,343)
Balance
Cash
45,985
47,852
Long term investments
Excess cash
44,396
46,493
Stockholders' equity
(98,763)
(98,929)
Invested Capital
152,206
155,499
ROIC
ROCE
EV
Common stock shares outstanding
16,578
15,386
Price
11.49
222.48%
3.56
-70.53%
Market cap
190,479
247.47%
54,819
-70.89%
EV
145,436
7,943
EBITDA
(3,482)
(11,148)
EV/EBITDA
Interest
48
46
Interest/NOPBT